It's not often that a pathologist gets to make a diagnosis that works for the patient by preventing treatment from occurring.

The standard measure of lesion count may matter less than the underlying biology driving treatment response in ...

Key market opportunities in tumor transcriptomics lie in addressing the growing demand for advanced diagnostic tools due to rising cancer cases. Continuous innovations in genomic sequencing and ...